Homology Medicines Inc., formed quietly last year, held its coming-out party by disclosing the close of a $43.5 million series A preferred stock financing co-led by 5AM Ventures and Arch Venture Partners, with participation from Singapore-based investment firm Temasek along with Deerfield Management and Arch Overage Fund.